Please ensure Javascript is enabled for purposes of website accessibility
network member

Wake Forest Baptist Medical Center Comprehensive Cancer Center

Winston-Salem, NC
Wake Forest Baptist Medical Center Comprehensive Cancer Center

About Network Member

Currently Enrolling

HCRN-AML24-687

Pilot Single Arm Phase 2 study of Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax
Cancer areas:Leukemia
Wake Forest Baptist Medical Center Comprehensive Cancer Center
Currently Enrolling

HCRN-AML20-472

TAGALONG Trial: Phase II Study of TAGraxofusp and Azacitidine With or Without Venetoclax in Newly Diagnosed Secondary AML after Previous Exposure to HypOmethylatiNG Agents
Cancer areas:Leukemia
AdventHealth Orlando
Penn Medicine Abramson Cancer Center
Rhode Island Hospital
Roswell Park Cancer Institute
Sylvester Comprehensive Cancer Center at the University of Miami
University of North Carolina Lineberger Comprehensive Cancer Center
Wake Forest Baptist Medical Center Comprehensive Cancer Center